He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca.
from NYT > Health https://ift.tt/3lZ33rR
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment